Speaker Q&A: What Breaks First When You Scale Oligos from IND to Commercial?
- Which early-stage assumptions around CPPs and impurity control most commonly fail at commercial scale?
- How to predict the point where oligo impurity complexity outpaces the existing analytical control strategy?
- What elements of process design, raw material qualification, or method validation are most frequently reworked post-Phase II, and why?